Albert C.

Trumansburg, NY

Albert C. | Trumansburg, NY
Age: 48  |  Location: Trumansburg, NY  |  Condition: Interstitial Lung Disease and Bronchiectasis

Over 12 years ago, Albert C. was exposed to toxic fumes in the workplace which led him to being diagnosed with interstitial lung disease (ILD) and bronchiectasis. Living in upstate New York and running his horse farm, these serious pulmonary conditions had a major effect on Albert’s life.

While researching alternative lung disease treatment options, Albert discovered stem cell therapy and the Lung Institute. After his treatment, he found his health had improved, and he felt better. Now, he’s able to get back to doing what he loves. Albert says, “It takes me less time and oxygen to tend to my horse farm.”

If you or someone you know is interested in stem cell therapy as a treatment for lung disease, please contact one of our patient coordinators at (800) 729-3065.

Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Thomas V.
Keene, NH
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Tammi S.
Cleveland, OH
Albert C.
Trumansburg, NY
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Sherry B.
Nashville, TN
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Peter P.
Cape Coral, FL
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Wayne H.
Houston, TX
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Harold T.
Birmingham, AL
Mike K.
Leesburg, FL
Jim D.
Boca Raton, FL
Jean H.
Houston, TX
Ike M.
Enterprise, MS
Marvin S.
Lakeland, FL
Edmond O.
Vermillion, SD
Vickie B.
San Antonio, TX

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.